|
|
||||||||
J Thorac Cardiovasc Surg 1996;112:832-833
© 1996 Mosby, Inc.
BRIEF COMMUNICATIONS |
New York, N.Y.
Received for publication Oct. 19, 1995 Accepted for publication Dec. 19, 1995. Address for reprints: Robert J. Downey, MD, Division of Thoracic Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021.
We report the case of a 67-year-old woman with Cushing's syndrome in whom somatostatin receptor scintigraphy was used to localize a corticotropin-producing pulmonary carcinoid tumor. Over several years, the patient had worsening depression, lower extremity edema, glucose intolerance, and severe muscle weakness. Eventually, she was taken comatose to another hospital. Initial evaluation revealed a serum potassium concentration of 1.9 mmol/L and a serum adrenocorticotropic hormone level of 132 pmol/L (normal range 9 to 52 pmol/L). Computed tomograms and magnetic resonance images of the abdomen and brain did not reveal any abnormalities. Thoracic computed tomography revealed a solitary 8 mm nodule in the peripheral right upper lobe without mediastinal adenopathy (Fig. 1). The patient was transferred to the Thoracic Surgical Service of Memorial Sloan-Kettering Cancer Center. Serum renin, aldosterone, calcitonin, and gastrin levels were within normal limits. Low- and high-dose dexamethasone suppression tests were performed without suppression of either serum or urinary cortisol levels. Somatostatin receptor scintigraphy demonstrated increased uptake in the right upper lobe of the lung that corresponded to the nodule seen on the computed tomographic scan; no additional abnormal areas of uptake were identified (Fig. 2). Through a limited right anterior thoracotomy, a 9 mm well-circumscribed nodule was excised from the anterior segment of the right upper lobe. Histologic examination revealed a well-differentiated pulmonary carcinoid tumor with positive staining for corticotropin hormone. Within several days, glucose and electrolyte levels returned to normal values, her depression lifted, and, with rehabilitation, muscle strength improved.
|
|
Recently, somatostatin receptors have been found to be expressed in the majority of carcinoid tumors. In vitro autoradiographic labeling of somatostatin analog binding sites was demonstrated in 54 of 62 carcinoid tumors
3 and correlates well with anatomic localization by somatostatin receptor scintigraphy.
4
Activated leukocytes, as accumulate in pulmonary granulomas or hilar lymph nodes with some autoimmune disorders, can be a source of false positive somatostatin receptor scans.
5 False positive lung scans have also been noted to result from increased hilar uptake after an upper respiratory tract infection, external beam irradiation, bleomycin administration, or surgical treatment.
5 However, if interpreted in an appropriate clinical setting, somatostatin receptor scintigraphy may provide an accurate, noninvasive technique for the characterization of indeterminate pulmonary nodules as hormonally active and should be considered in the diagnostic evaluation of the patient with Cushing's syndrome.
Footnotes
From the Divisions of Thoracic Surgery,a Nuclear Medicine,b and Critical Care,c Memorial Sloan-Kettering Cancer Center, New York, N.Y. ![]()
J THORAC CARDIOVASC SURG 1996;112:832-3 ![]()
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |